INTERNATIONAL PATENT: INCYTE CORPORATION FILES APPLICATION FOR "TOPICAL SKIN FORMULATIONS OF A PHARMACEUTICALLY ACCEPTABLE SALT OF RUXOLITINIB"

GENEVA, March 11 -- INCYTE CORPORATION (1801 Augustine Cut-OffWilmington, Delaware 19803) filed a patent application (PCT/US2025/043297) for "TOPICAL SKIN FORMULATIONS OF A PHARMACEUTICALLY ACCEPTABLE SALT OF RUXOLITINIB" on Aug 25, 2025. With publication no. WO/2026/050130, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ELLIOTT, Russell (c/o Incyte Corporation1801 Augustine Cut-OffWilmington, Delaware 19803), JIA, Zhongjiang (c/o Incyte Corporation1801 Augustine Cut-OffWilmington, Delaware 19803), LAWRENCE, Gary (c/o In...